Table 1.
Study | Year | Number of patients | Study design | Primary tumour detection rate (%) | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|---|---|
Regelink et al18 | 2002 | 50 | Retrospective | 32 | 100 | 94 |
Stockeli et al19 | 2003 | 18 | Prospective | 33 | 63 | 90 |
Gutzeit et al20 | 2005 | 18 | Retrospective | 33 | 35 | 0 (0/1) |
Freudenberg et al25 | 2005 | 21 | Retrospective | 57 | 86 | 100 |
Fakrhy et al21 | 2006 | 22 | Retrospective | 32 | 70 | 75 |
Nassenstein et al22 | 2007 | 39 | NR | 28 | 100 | 85 |
Wartski et al23 | 2007 | 38 | Retrospective | 34 | 93 | 73 |
Johansen et al26 | 2008 | 60 | Prospective | 37 | 87 | 68 |
Rogh et al27 | 2009 | 44 | Retrospective | 43 | 87.5 | 82.1 |
Zhao et al28 | 2012 | 25 | Retrospective | 84 | 73.3 | 28.6 |
Wong et al24 | 2012 | 78 | Retrospective | 38.5 | 100 | 66.7 |
Pereira et al29 | 2012 | 49 | Retrospective | 18.4 | 69.2 | 81.6 |
Lee et al30 | 2015 | 56 | Prospective | 50 | 69 | 88 |
NR, not reported.